Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00343_DB01072_nanopub.RA52b7_C1YaAjs7PtixcDmOW9YQsTWvkcVDZHlI946qso#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00343_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00343_DB01072 label "DDI between Diltiazem and Atazanavir - Atazanavir may increase the therapeutic and adverse effects of diltiazem resulting in increased risk of AV block. Consider alternate therapy, a 50% dose reduction of diltiazem and monitor for changes in the therapeutic and adverse effects of diltiazem if atazanavir is initiated, discontinued or dose changed. [drugbank_resource:DB00343_DB01072]" assertion.
- drugbank_resource:DB00343_DB01072 identifier "drugbank_resource:DB00343_DB01072" assertion.
- drugbank_resource:DB00343_DB01072 title "DDI between Diltiazem and Atazanavir - Atazanavir may increase the therapeutic and adverse effects of diltiazem resulting in increased risk of AV block. Consider alternate therapy, a 50% dose reduction of diltiazem and monitor for changes in the therapeutic and adverse effects of diltiazem if atazanavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00343 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00343_DB01072 assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00343_DB01072 assertion.